A phase I multiple-ascending dose clinical trial of APD371
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2018
At a glance
- Drugs Olorinab (Primary)
- Indications Pain
- Focus Adverse reactions
- 01 Mar 2018 Data from this trial will be presented at the American Pain Society (APS) Annual Scientific Meeting 2018, according to an Arena Pharmaceuticals media release.
- 09 May 2016 According to an Arena Pharmaceuticals media release, favourable results from this trial were announced in the first quarter of 2016.
- 09 May 2016 Status changed from recruiting to completed, as per information provided in an Arena Pharmaceuticals media release.